Australia Stock Investment Portal | I3investor

Telix Pharmaceuticals Limited

ASX (AUD): Telix Pharmaceuticals Limited (TLX)

Last Price

23.05

Today's Change

-0.42 (1.78%)

Day's Change

23.00 - 23.36

Trading Volume

163,348

Key Executives

Name	Title	Pay	Currency	Year Born	Title Since

Discussions

Be the first to like this. Showing 0 of 0 comments

Post a Comment

Latest Videos

MQ Market Updates - 11 November 2024

MQ Trader

Apps

Send individual or group chats with anyone on i3investor

Earn MQ Points while trading with MQ Trader

MQ Affiliate

Earn side income from Affiliate Program

Online learning and teaching marketplace

Top Articles

1

CEO Morning Brief

Australia Faces Economic Pain From Trump Win, Treasurer Warns

2

CEO Morning Brief

Australia to Ban Social Media for Children Under Age 16

Hot Stocks Today >

1

Lynas Rare Earths Limited

1000

2

Corporate Travel Management Limited

500

3

500

4

Domino's Pizza Enterprises Limited

500

5

Incitec Pivot Limited

500

6

Macmahon Holdings Limited

500

7

Transurban Group

500

8

500

9

Rio Tinto Group

500

10

Vita Group Limited

500

Daily Stocks

0.019

+0.003

35,454,820

0.022

0.00

20,994,750

0.014

+0.002

16,117,366

0.002

0.00

8,040,702

0.053

-0.003

6,701,216

0.29

+0.01

6,212,562

0.015

+0.002

6,208,609

0.024

0.00

6,080,516

0.029

+0.002

5,737,921

0.002

0.00

5,608,166

More active Stocks

131.24

+4.84

182,134

52.35

+2.11

849,908

111.00

+1.89

2,807

11.68

+0.73

237,884

26.33

+0.62

126,521

152.23

+0.49

1,118

36.42

+0.47

13,154

31.02

+0.39

5,219

7.20

+0.32

2,133,531

90.06

+0.29

6,094

More gainer Stocks

113.83

-3.71

288,723

62.61

-3.38

6,851

238.83

-3.325

7,350

201.32

-3.31

10,910

296.77

-2.64

7,729

35.03

-2.63

642,777

190.77

-2.22

1,952

285.00

-1.66

36,786

229.59

-1.61

38,759

148.70

-1.55

170,989

More loser Stocks

Top Brokers >

Books Review >

Ride The Bull Short The Bear

CS Tan

4.9 / 5.0

This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....